Transcript Kenya National Drug Policy Implementation Programme (KNDIP)

Kenya National Drug Policy
Implementation Programme
(KNDIP)
1|
Futurefrom
of Essential
TITLE
VIEW andMedicines
SLIDE MASTER | 27 July 2006
Before KNDIP
The MOH was already working with:
 Health Sector Support Programme (DANIDA) in
strengthening the Medical Supplies Co-ordination Unit
(MSCU) and drug procurement,
 Financing and Sustainability Project, which assisted in
cost sharing and supply (APHIA, MSH/USAID) and GTZ
support to the National Drug Quality Control Laboratory
for quality control of drugs
2|
Futurefrom
of Essential
TITLE
VIEW andMedicines
SLIDE MASTER | 27 July 2006
KNDIP
 Formulated between 1991-93 through a series of national
consensus building workshops.
 All stakeholders, including the public, private and nongovernmental sectors, were represented in these
discussions.
 The Drug Action Programme (DAP) of WHO provided
both technical as well as financial assistance to this
process in general, and the formulation of the
implementation plan (POO) in particular.
3|
Futurefrom
of Essential
TITLE
VIEW andMedicines
SLIDE MASTER | 27 July 2006
The design:
 Endorsement of the NDP at the Cabinet level took place 1994, and
this facilitated the development of the POO in 1995.
 In July 1995, the Netherlands Government agreed to fund the
implementation of specific components of the NDP to be
implemented through WHO/DAP, for a total of US$ 2,636,000 over
a period of five years.
 The implementation of the NDP activities was to be undertaken as
part of the overall health sector reforms in the MOH.
 Actual implementation work commenced the second half of 1996.
4|
Futurefrom
of Essential
TITLE
VIEW andMedicines
SLIDE MASTER | 27 July 2006
The Goal:
The goal of the Kenya National Drug Policy (KNDP):
to ensure the constant availability of safe,
efficacious, high quality and cost-effective
pharmaceutical products for the purposes of
prevention, diagnosis and treatment of diseases in
the Kenyan population.
5|
Futurefrom
of Essential
TITLE
VIEW andMedicines
SLIDE MASTER | 27 July 2006
The Objectives:
 ensure constant availability of safe and effective drugs to all
segments of the population;
 provide drugs through the different sectors at affordable prices;
 facilitate rational use of drugs through sound prescribing,
dispensing, and usage;
 ensure that the quality of drugs manufactured in Kenya and those
imported into Kenya meet internationally accepted quality standards;
 encourage self sufficiency through local manufacture of drugs for
consumption and export;
 ensure that the provision of drugs for veterinary services is
consistent with the KNDP
6|
Futurefrom
of Essential
TITLE
VIEW andMedicines
SLIDE MASTER | 27 July 2006
Constraints faced:
 Long delays in recruitment of staff
 Monitoring and evaluation of the Programme was not been
routinely undertaken although a technical working group had
been established.
 Programme management had not been optimal and needed to be
strengthened in order to enable the programme to fulfil its coordinating role
 The rather loose management organisation structure - lack of:
contractual arrangements (with MOH) and managerial
procedures
7|
Futurefrom
of Essential
TITLE
VIEW andMedicines
SLIDE MASTER | 27 July 2006
Project Assessment:
 NPTC operationalised and KEDL and Clinical Guidelines
reviewed, and updated.
 Training in RDU for Nurses, Clinical Officers, Pharmaceutical
Technologists updated.
 KNDPIP had facilitated the process of autonomization of MSCU.
 KNDPIP had facilitated (further) the process of autonomization of
PPB
 KNDPIP was instrumental in facilitating involvement of
development partners (USAID, DANIDA, and RNE) private
sector, NGOs, in planning for improving public drug supply
system.
8|
Futurefrom
of Essential
TITLE
VIEW andMedicines
SLIDE MASTER | 27 July 2006